期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders
1
作者 libia vega Guillermo Elizondo 《World Journal of Pharmacology》 2013年第4期107-114,共8页
The aryl hydrocarbon receptor (AhR) was discovered more than three decades ago, and initially was char-acterized as a transcription factor with a role in xe-nobiotic metabolism. However, based on subsequent observat... The aryl hydrocarbon receptor (AhR) was discovered more than three decades ago, and initially was char-acterized as a transcription factor with a role in xe-nobiotic metabolism. However, based on subsequent observations that AhR remains active under physiologi-cal conditions, exhibits constitutive expression during development, and has a high degree of conservation among species, it was hypothesized that AhR is re-sponsible for functions in addition to its role in detoxif-cation. Correspondingly, recent studies have elucidated novel physiological roles for this ligand-dependent transcription factor that link it to several pathways associated with disease development. In this review, studies are presented that support a role for AhR in cell proliferation, apoptosis, and immune homeostasis, thereby highlighting the therapeutic potential of this receptor for cancer and immune disorders. 展开更多
关键词 Aryl hydrocarbon receptor Cell proliferation APOPTOSIS IMMUNITY CANCER
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部